ALEC
Alector Inc
NASDAQ: ALEC · HEALTHCARE · BIOTECHNOLOGY
$2.37
+3.04% today
Updated 2026-04-30
Market cap
$255.36M
P/E ratio
—
P/S ratio
12.13x
EPS (TTM)
$-1.39
Dividend yield
—
52W range
$1 – $3
Volume
0.7M
Alector Inc (ALEC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.99M | $-17.77M | $127.46M | $-99.31M | $-166.73M | $298.55M | $-20.33M | $-184.16M | $-229.91M | $-184.03M |
| Capital expenditures | $2.25M | $801000.00 | $1.88M | $15.27M | $5.03M | $3.25M | $4.12M | $2.38M | $1.25M | $41000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.96M | $5.35M | $6.92M | $16.28M | $30.52M | $40.78M | $46.15M | $42.80M | $39.46M | $26.66M |
| Free cash flow | $-15.24M | $-18.57M | $125.58M | $-114.57M | $-171.77M | $295.30M | $-24.45M | $-186.54M | $-231.16M | $-184.07M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $24.17M | $-39.67M | $279.18M | — | — | — | — |